This article is more than 5 years old. Information may no longer be current.
Top stories in gastroenterology: Future of colorectal cancer screening, separating fact from fiction in a patient with Crohn’s disease
Click Here to Manage Email Alerts
Among the top stories in gastroenterology last week were a video interview from GI Outlook 2019 that focused on the future of colorectal cancer screening and its viability in practice management and a guest commentary that provided tips on separating fact from fiction in a recent report regarding a patient with Crohn’s disease.
Other highlights included a study that found certain factors may influence behavioral therapy response in supragastric belching, research that suggested potential consequences for pediatric patients with ulcerative colitis who do not adhere to treatment with mesalamine and a video interview discussing the steps needed to bring value-based medicine to the United States.
VIDEO: ‘Good, bad news’ for the future of colorectal cancer screening
LOS ANGELES — In this exclusive video from GI Outlook 2019, T.R. Levin, MD, the chief of gastroenterology at Kaiser Permanente Medical Center, discusses the future of colorectal cancer screening and its viability in practice management. Read more.
‘Hype vs. science’: Identifying, disseminating nutrition data that matters
In this guest commentary, Kate Scarlata, MPH, RDN, a Boston-based registered dietitian, addressed a recent case report that indicated that a plant-based diet induced remission in a patient with Crohn’s disease. Read more.
Certain factors may influence behavioral therapy response in supragastric belching
Several factors, including lower hypervigilance, are associated with better outcomes of cognitive behavioral therapy in patients with supragastric belching, according to study results. Read more.
Treatment nonadherence predicts escalation in children with ulcerative colitis
Pediatric patients with ulcerative colitis who do not adhere to treatment with mesalamine may experience a decrease in therapeutic efficacy, leading to a need for treatment escalation, a report in Alimentary Pharmacology & Therapeutics concluded. Read more.
VIDEO: Bringing value-based medicine pricing, access to the U.S.
LOS ANGELES — In this exclusive video from GI Outlook 2019, James C. Robinson, PhD, MPH, professor of health economics at the University of California Berkeley, discusses the steps needed to bring true, value-based medicine to the United States. Read more.